Myriad Genetics, Inc. (MYGN)
5.66
-0.02
(-0.35%)
USD |
NASDAQ |
Nov 13, 16:00
5.645
-0.02
(-0.27%)
After-Hours: 19:59
Myriad Genetics Total Liabilities (Quarterly) : 340.20M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 340.20M |
| June 30, 2026 | 335.00M |
| March 31, 2026 | 336.30M |
| December 31, 2025 | 338.60M |
| September 30, 2025 | 355.30M |
| June 30, 2025 | 289.20M |
| March 31, 2025 | 301.20M |
| December 31, 2024 | 326.50M |
| September 30, 2024 | 349.60M |
| June 30, 2024 | 344.60M |
| March 31, 2024 | 350.50M |
| December 31, 2023 | 463.30M |
| September 30, 2023 | 465.70M |
| June 30, 2023 | 452.00M |
| March 31, 2023 | 334.10M |
| December 31, 2022 | 431.40M |
| September 30, 2022 | 295.40M |
| June 30, 2022 | 262.80M |
| March 31, 2022 | 305.30M |
| December 31, 2021 | 445.70M |
| September 30, 2021 | 367.40M |
| June 30, 2021 | 457.90M |
| March 31, 2021 | 461.70M |
| June 30, 2020 | 625.90M |
| March 31, 2020 | 479.50M |
| Date | Value |
|---|---|
| December 31, 2019 | 501.00M |
| September 30, 2019 | 516.70M |
| June 30, 2019 | 576.80M |
| March 31, 2019 | 475.60M |
| December 31, 2018 | 492.50M |
| September 30, 2018 | 471.40M |
| June 30, 2018 | 261.40M |
| March 31, 2018 | 270.10M |
| December 31, 2017 | 314.30M |
| September 30, 2017 | 357.70M |
| June 30, 2017 | 539.90M |
| March 31, 2017 | 519.90M |
| December 31, 2016 | 543.40M |
| September 30, 2016 | 535.60M |
| June 30, 2016 | 195.60M |
| March 31, 2016 | 98.00M |
| December 31, 2015 | 100.90M |
| September 30, 2015 | 99.90M |
| June 30, 2015 | 104.10M |
| March 31, 2015 | 99.70M |
| December 31, 2014 | 87.61M |
| September 30, 2014 | 96.86M |
| June 30, 2014 | 104.82M |
| March 31, 2014 | 94.18M |
| December 31, 2013 | 80.71M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Labcorp Holdings, Inc. | 10.06B |
| Natera, Inc. | 878.86M |
| Sera Prognostics, Inc. | 27.54M |
| BioRestorative Therapies, Inc. | 1.615M |
| CareDx, Inc. | 174.00M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 609.20M |
| Shareholders Equity (Quarterly) | 269.00M |
| Debt to Equity Ratio | 0.7784 |
| Current Ratio | 1.976 |
| Net Debt Paydown Yield | -2.66% |